Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study.

@article{Manzi1997AgespecificIR,
  title={Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study.},
  author={Susan Manzi and Elaine N. Meilahn and J E Rairie and C G Conte and Thomas A. Medsger and Linda Jansen-Mcwilliams and Ralph B. D'Agostino and Lewis H. Kuller},
  journal={American journal of epidemiology},
  year={1997},
  volume={145 5},
  pages={
          408-15
        }
}
The authors ascertained cardiovascular events (myocardial infarction and angina pectoris) in 498 women with systemic lupus erythematosus seen at the University of Pittsburgh Medical Center from 1980 to 1993 (3,522 person-years). Subjects were stratified by age, and cardiovascular event incidence rates were determined. The authors compared these rates with cardiovascular event rates were determined. The authors compared these rates with cardiovascular event rates occurring over the same time… 

Tables from this paper

Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus.

TLDR
Although it is important to address the management of orthodox risk factors for cardiovascular disease in patients with SLE, other causes must be sought to explain the increased incidence of CHD and stroke, especially in those aged over 40.

Cardiovascular event in systemic lupus erythematosus in northern Sweden: Incidence and predictors in a 7-year follow-up study

TLDR
The risk of a CVE, or MI, was eight- or nine-fold greater among middle-aged female SLE patients and was associated with SLE-related factors including hypertension and age.

High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors.

TLDR
The increased incidence of CV events in RA patients is independent of traditional CV risk factors, which suggests that additional mechanisms are responsible for CV disease in RA.

Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study.

TLDR
A prospective population-based study among 119,332 women participating in the Nurses' Health Study found a statistically significant >2-fold increased risk of cardiovascular disease among participants with SLE.

Mortality and Cardiovascular Burden of Systemic Lupus Erythematosus in a US Population-based Cohort

TLDR
This incident SLE cohort demonstrated nearly doubled mortality and CVD event hazards compared to age-matched and sex-matched comparisons, even after accounting for higher CVD events in the 2 years preceding SLE diagnosis, which raises research questions regarding delayed Sle diagnosis versus accelerated CVD prior to SLE.

Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study.

TLDR
Women with SLE have a range of detectable coronary risk factors that are not fully reflected in the Framingham risk factor formula and are likely to contribute to the loss of protection from CHD that has been observed in SLE.

Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus.

  • M. Ward
  • Medicine, Political Science
    Arthritis and rheumatism
  • 1999
TLDR
Young women with SLE are at substantially increased risk of AMI, CHF, and CVA, and the relative odds of these conditions decrease with age among women withSLE.

Cardiovascular risk scores and the presence of subclinical coronary artery atherosclerosis in women with systemic lupus erythematosus

TLDR
The data indicate that cardiovascular risk scores are not adequate for risk stratification in women with SLE and measurement of coronary calcification may add information to identify asymptomatic women with lupus who might benefit from aggressive preventive measures.

Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus.

TLDR
There is a substantial and statistically significant increase in CHD and stroke in SLE that cannot be fully explained by traditional Framingham risk factors alone.
...

References

SHOWING 1-10 OF 54 REFERENCES

Prevalence of cardiovascular diseases among older adults. The Cardiovascular Health Study.

TLDR
The results suggest that prevalent disease estimates based only on self-report may underestimate the prevalence of cardiovascular diseases in older Americans.

The Cardiovascular Health Study: design and rationale.

The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial.

The relation between serum albumin levels and subsequent incidence of myocardial infarction and coronary heart disease deaths was evaluated using stored serum from the Multiple Risk Factor

Risk factors that attenuate the female coronary disease advantage.

TLDR
Coronary disease is not a minor problem in women, and women should take vigorous preventive measures, including particular attention to glucose tolerance and blood lipid levels and a greater sense of urgency when hypertension progresses to left ventricular hypertrophy.

An investigation of coronary heart disease in families. The Framingham offspring study.

TLDR
There is little evidence that coronary heart disease (CHD) experience and CHD risk factors differ in parents of those who volunteered for this study and the parents ofThose who did not volunteer.

Myocardial infarction in four young patients with SLE.

TLDR
Four patients with chronic systemic lupus erythematosus in whom myocardial infarction occurred at an unusually early age are described and it is suggested that hypertension aggravated by chronic corticosteroid administration may be an important risk factor for atherosclerosis in patients with SLE.

Ischemic heart disease in systemic lupus erythematosus. A retrospective study of 65 patients treated with prednisolone.

TLDR
Regular ECG check up for SLE patients while they are on low dose PSL or pulse therapy may help reveal early ECG abnormalities and thus detect and treat one of the major risks of long-term effects of corticosteroid therapy.
...